Encapsulating therapeutic antibodies for tumor specific activation and delivery using a clinically validated pH-sensitive nanoparticle platform

ON-BOARD™
Written By Brad Good
Brad Good

Brad Good has been an endorsed Squarespace Expert since the beginning and has been working on the platform since 2008. He has helped hundreds of Squarespace customers with their websites.

http://www.bradgood.net
Previous

ONM-501 – A polyvalent STING agonist for oncology immunotherapy
Next

Prolonged activation of innate immune pathways by a polyvalent STING agonist